Volume therapy in cardiac surgery: Are Americans different from Europeans?

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 20, Issue 1, 2006, Pages 98-105

  Boldt, Joachim ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Cardiac surgery; Europe; Hypovolemia; Outcome; United States; Volume replacement

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH; ISOTONIC SOLUTION; PLASMA SUBSTITUTE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ANAPHYLAXIS; BLEEDING; BLOOD CLOTTING; BLOOD SUBSTITUTION; CLINICAL TRIAL; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG URINE LEVEL; EUROPE; HEART SURGERY; HEART VOLUME; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPOVOLEMIA; INFLAMMATION; KIDNEY DYSFUNCTION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNITED STATES; UNSPECIFIED SIDE EFFECT;

BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; EUROPE; HETASTARCH; HUMANS; PLASMA SUBSTITUTES; RENIN-ANGIOTENSIN SYSTEM; UNITED STATES; VASOPRESSINS;

EID: 31844434861     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2005.07.023     Document Type: Review

References (62)

1. P. Hebert, G. Wells, A. Blajchman A multicenter randomized, controlled clinical trial of transfusion requirements in critical care N Engl J Med 340 1999 409 417
2. K. Holte, N.E. Shorrock, H. Kehlet Pathophysiology and clinical implications of perioperative fluid excess Br J Anaesth 89 2002 622 632
3. R.J. Traylor, R. Pearl Crystalloid versus colloid All colloids are not created equal Anesth Analg 83 1996 209 212
4. L.C. Vermeulen, M.A. Ratko, B.L. Estad A paradigm for consensus - The university hospital consortium guidelines for the use of albumin, nonprotein colloids, and crystalloid solutions Arch Intern Med 155 1995 373 379
5. G. Schierhout, I. Roberts Fluid resuscitation with colloids or crystalloids in critically ill patients A systematic review of randomised trials BMJ 316 1998 961 964
6. B.B. Warren, M.E. Durieux Hydroxyethyl starch Safe or not? Anesth Analg 84 1997 206 212
7. N. Soni Wonderful albumin? BMJ 310 1995 887 888
8. M.P. Margarson, N. Soni Serum albumin Touchstone or totem? Anaesthesia 53 1998 789 803
9. J.N. Hoffmann, B. Vollmar, M.W. Laschke Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia Anesthesiology 97 2002 460 470
10. M.S. Karanko, J.A. Klossner, V.O. Laaksonen Restoration of volume by crystalloids versus colloid after coronary artery bypass Hemodynamics, lung water, oxygenation, and outcome Crit Care Med 15 1987 559 566
11. J.P. Depoix, Y. Pansard, M. Vidocq Mesure preoperatoire de la volemie chez les patients devant subir un pontage aorto-coronarien Ann Franc Anesth Reanimat 2 1983 392 395
12. R.C. Lillehei The nature of irreversible shock Ann Surg 4 1964 682 686
13. H.L. Edmunds Jr Blood surface interactions during cardiopulmonary bypass J Card Surg 8 1993 404 410
14. R. Butler, G.M. Rocker, S. Westaby Inflammatory response to cardiopulmonary bypass Ann Thorac Surg 55 1993 552 559
15. L.C. Casey Role of cytokines in the pathogenesis of cardiopulmonary- induced multisystem organ failure Ann Thorac Surg 56 1993 S92 S96
16. R.I. Hall, M.S. Smith, G. Rocker The systemic inflammatory response to cardiopulmonary bypass Pathophysiological, therapeutic, and pharmacological considerations Anesth Analg 85 1997 766 782
17. H. Haljamae Volume substitution in shock Acta Anaesthesiol Scand 37 suppl 1993 25 28
18. M.H. Weil Crystalloid, colloids, and fluid compartments Crit Care Med 27 1999 3 4
19. J.H. Waters, A. Gottlieb, P. Schoenwald Normal saline versus Ringer's lactate solutions for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair an outcome study Anesth Analg 93 2001 817 822
20. A. Pope, G. French, D.E. Longnecker Fluid Resuscitation State of the Science for Treating Combat Casualties and Civilian Injuries 1999 National Academy Press Washington DC
21. K. Jarvela, S. Kaukinen Hypertonic saline (7.5%) decreases perioperative weight gain following cardiac surgery J Cardiothorac Vasc Anesth 16 2002 43 46
22. Evidence-based colloid use in the critically ill American Thoracic Society Consensus Statement Am J Respir Crit Care Med 170 2004 1247 1259
23. J. Treib, A. Haass, G. Pindur Coagulation disorders caused by hydroxyethyl starch Thromb Haemost 78 1997 974 983
24. J. Treib, J.F. Baron, M.T. Grauer An international view of hydroxyethyl starches Intensive Care Med 25 1999 258 268
25. E. De Jonge, M. Levi Effect of different plasma substitutes on blood coagulation a comparative review Crit Care Med 29 2001 1261 1267
26. W.C. Winkelmayer, R.J. Glynn, R. Levin Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery Kidney Int 64 2003 1046 1049
27. C. Jungheinrich, R. Scharpf, M. Wargenau The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment Anesth Analg 95 2002 544 551
28. J. Boldt, T. Brenner, A. Lehmann Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery Comparison of a new starch preparation with gelatin Intensive Care Med 29 2003 763 769
29. L.A. Herwaldt, S.K. Swartzendruber, M.B. Edmond The epidemiology of hemorrhage related to cardiothoracic operations Infect Control Hosp Epidemiol 19 1998 6 16
30. J.T. Cope, D. Banks, M.C. Mauney Intraoperative hetastarch infusion impairs hemostasis after cardiac surgery operations Ann Thorac Surg 63 1997 78 82
31. C.C. Canver, R.D. Nichols Use of intraoperative hetastarch priming during coronary bypass Chest 118 2000 1616 1620
32. J. Avorn, M. Patel, R. Levin Hetastarch and bleeding complications after coronary artery surgery Chest 124 2003 1437 1442
33. J.E. Knutson, J.A. Deering, F.W. Hall Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery Anesth Analg 90 2000 801 807
34. A.H. Kuitunen, M.J. Hynynen, E. Vahtera Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery Anesth Analg 98 2004 291 297
35. J. Boldt, C. Knothe, B. Zickmann Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass Anesth Analg 76 1993 1185 1190
36. A. Franz, P. Bräunlich, T. Gamsjäger The effects of hydroxyethyl starches of varying molecular weights on platelet function Anesth Analg 92 2001 1402 1407
37. R.G. Strauss Volume replacement and coagulation a comparative review J Cardiothorac Anesth 2 1988 24 32
38. M.M. Wilkes, R.J. Navickis, W.J. Sibbald Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery A meta-analysis of postoperative bleeding Ann Thorac Surg 72 2001 527 533
39. M.E. Barron, M.M. Wilkes, R.J. Navickis A systematic review of the comparative safety of colloids Arch Surg 139 2004 552 563
40. G.R. Haynes, R.J. Navickis, M.M. Wilkes Albumin administration-What is the evidence of clinical benefit? A systematic review of randomized controlled trials Eur J Anaesthesiol 20 2003 771 793
41. M.M. Wilkes, R.J. Navickis Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials Ann Intern Med 135 2001 149 164
42. J.A. Russell, R.J. Navickis, M.M. Wilkes Albumin versus crystalloid for pump priming in cardiac surgery Meta-analysis of controlled trials J Cardiothorac Vasc Anesth 18 2001 429 437
43. L.Q. Riegger, T. Voepel-Lewis, T.J. Kulik Albumin versus crystalloid prime solution for cardiopulmonary bypass in young children Crit Care Med 30 2002 2649 2654
44. A. Sedrakyan, K. Gondek, D. Paltiel Volume expansion with albumin decreases mortality after coronary artery bypass graft surgery Chest 123 2003 1853 1857
45. T.J. Gan, E. Bennett-Guerrero, B. Phillips-Bute Hextend, a physiologically balanced plasma expander for large volume use in major surgery A randomized phase III clinical trial Anesth Analg 88 1999 992 998
46. N.J. Wilkes, R.L. Woolf, M.C. Powanda Hydroxyethyl starch in balanced electrolyte solution (Hextend - Pharmacokinetic and pharmacodynamic profiles in healthy volunteers Anesth Analg 94 2002 538 544
47. G. Martin, E. Bennett-Guerrero, H. Wakeling A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hydroxyethyl starch in saline during major surgery J Cardiothorac Vasc Anesth 16 2002 441 446
48. J. Boldt, G. Haisch, S. Suttner Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation Br J Anaesth 89 2002 722 728
49. M.D. Tobias, D. Wambold, M.A. Pilla Differential effects of serial hemodilution with hydroxyethyl starch, albumin, and 0.9% saline on whole blood coagulation J Clin Anesth 10 1998 366 371
50. H.S. Nearman, M.L. Herman Toxic effects of colloids in the intensive care unit Crit Care Clin 7 1991 713 723
51. J. Waitzinger, F. Bepperling, G. Pabst Hydroxyethyl starch (HES) [130/0.4], a new HES specification Pharmacokinetics and safety after multiple infusions of 10% solution in healthy volunteers Drugs R D 4 2003 149 157
52. B. Stögermüller, J. Stark, H. Willschke The effect of hydroxyethyl starch 200 kD on platelet function Anesth Analg 91 2000 823 827
53. M. Jamnicki, T. Bombelli, B. Seifert Low- and medium-molecular-weight hydroxyethyl starches - Comparison of their effects on blood coagulation Anesthesiology 93 2000 1231 1237
54. G. Haisch, J. Boldt, C. Krebs The influence of a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in cardiac surgical patients J Cardiothorac Vasc Anesth 15 2001 316 321
55. R.C.G.G. Huet, A.W. Siemons, D. Baus A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery Can J Anesth 47 2000 1207 1215
56. S.M. Kasper, P. Meinert, S. Kampe Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses Anesthesiology 99 2003 42 47
57. G.H. Haynes, J.E. Havidich, K.J. Payne Why the Food and Drug Administration changed the warning label for hetastarch Anesthesiology 101 2004 560 561
58. I. Roberts, F. Bunn Egg on their faces Eval Health Prof 25 2002 130 138
59. R.J. Frumento, E. Bennett-Guerrero A Society of Cardiovascular Anesthesiologists Monograph Systemic inflammatory response syndrome and organ dysfunction Opportunities for treatment M.F. Newman Perioperative Organ Protection 2003 Lipincott Williams & Wilkins Philadelphia, PA S27 S32
60. F. Schortgen, N. Deye, L. Brochard CRYCO Study Group Preferred plasma volume expanders for critically ill patients results of an international survey Intensive Care Med 30 2004 2222 2229
61. J.M. Mishler, H. Borberg, P.M. Emerson Hydroxyethyl starch An agent for hypovolemic shock treatment J Surg Res 23 1977 239 245
62. G. Lehmann, F. Askali, H. Förster Pharmakokinetics of hydroxyethyl starch (70/0.5) following repeated infusions Transfus Med Hemother 30 2003 72 77